Showing results (91-100 of 354) with videos related to
Sort By:
Pageof 36
The Journal of Cell Biology|December 21, 2000
Reversal of the Ras-induced transformed phenotype by HR12, a novel ras farnesylation inhibitor, is mediated by the Mek/Erk pathwayH Reuveni, T Geiger, B Geiger, et al.European Journal of Biochemistry|August 1, 1983
Reconstitution of a functional beta-adrenergic receptor using cholate and a novel method for its functional assayA Gal, S Braun, D Feder, et al.Science (New York, N.Y.)|November 11, 1988
Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitorsP Yaish, A Gazit, C Gilon, et al.American Journal of Audiology|October 5, 2018
Factors Associated With Self-Reported Hearing Aid Management Skills and KnowledgeRebecca J Bennett, Carly J Meyer, Robert H Eikelboom, et al.Journal of Medicinal Chemistry|December 6, 1996
Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitroA Gazit, N Osherov, C Gilon, et al.Cancer Journal (Sudbury, Mass.)|October 19, 2000
An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studiesH He, Y Hirokawa, A Levitzki, et al.The Journal of Biological Chemistry|May 25, 1993
Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostinsN Osherov, A Gazit, C Gilon, et al.FEBS Letters|November 6, 1989
Tyrphostins inhibit the epidermal growth factor receptor-mediated breakdown of phosphoinositidesI Posner, A Gazit, C Gilon, et al.Bioorganic & Medicinal Chemistry|September 11, 1999
Alpha-cyanocinnamide derivatives: a new family of non-peptide, non-sulfhydryl inhibitors of Ras farnesylationE Poradosu, A Gazit, H Reuveni, et al.Molecular and Cellular Biology|September 21, 2001
Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stressM Benhar, I Dalyot, D Engelberg, et al.Pageof 36